Stock data
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN) reported net income of -US$17.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$17.98M | -US$17.12M | — |
| 2024 | — | — | -US$22.22M | -US$20.78M | — |
| 2023 | — | — | -US$17.88M | -US$15.96M | — |
| 2022 | — | — | -US$14.43M | -US$14.26M | — |
| 2021 | — | — | -US$12.59M | -US$12.36M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$7.07M | — |
| 2026-03-31 | — | -US$3.33M | — |
| 2025-12-31 | — | -US$4.07M | — |
| 2025-09-30 | — | -US$4.18M | — |
| 2025-06-30 | — | -US$4.33M | — |
| 2025-03-31 | — | -US$4.54M | — |
| 2024-12-31 | — | -US$5.88M | — |
| 2024-09-30 | — | -US$4.51M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.